JPRN-UMIN000050622尚未招募Unknown
Benefit-risk profile in P2X3 receptor antagonists for treatment of chronic cough: Dose-response model-based network meta-analysis - Benefit-risk profile in P2X3 receptor antagonists for treatment of chronic cough: Dose-response model-based network meta-analysis
适应症
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Other
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •We excluded studies that compared P2X3 receptor antagonists with any other active treatment, as well as animal trials, abstracts, and any study designs other than RCTs.
研究者
相似试验
已完成
2 期
Evaluate, Safety and Tolerability of Intraprostatic PRX302 Administration, Low to Intermediate Risk Prostate CancerProstate CancerNCT02499848Sophiris Bio Corp18
尚未招募
不适用
The effect of a beta-3 adrenergic receptor agonist on metabolic disease in humans.ACTRN12618001449224Baker Heart and Diabetes Institute60
已完成
1 期
Multiple Ascending Oral Dose Phase I Study With Px-102HealthyNCT01998672Phenex Pharmaceuticals AG42
已完成
2 期
Transperineal Intraprostatic Injection of PRX302 Under Ultrasound Guidance for Management of Prostatic HyperplasiaBenign Prostatic HyperplasiaNCT00889707Sophiris Bio Corp92
已完成
1 期
Single Ascending Oral Dose Phase I Study With Px-102HealthyNCT01998659Phenex Pharmaceuticals AG54